Terns Pharmaceuticals, Inc.

Man Group plc TERN
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
284,931
Value ($000)
15,022
Weight
0.0%
2022 Q4 - 2026 Q1 (4 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).